Financhill
Back

Viatris 10K Form

Sell
32

VTRS
Viatris

Last Price:
11.6200
Seasonality Move:
8.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive VTRS News And Ratings

See the #1 stock for the next 7 days that we like better than VTRS

VTRS Financial Statistics

Sales & Book Value

Annual Sales: $15.43B
Cash Flow: $309.6M
Price / Cash Flow: 7.33
Annual Sales: $16.36
Price / Book: 0.7

Profitability

EPS (TTM): -0.55000
Net Income (TTM): $-646.5M
Gross Margin: $6.44B
Return on Equity: -3.18%
Return on Assets: -1.36%

Viatris Earnings Forecast

Key Viatris Financial Ratios

  • The Gross Profit Margin over the past 40 years for VTRS is 41.74%.
  • The Selling, General & Administrative Expenses for VTRS have been equal to 30.14% of Gross Profit Margin.
  • The Research & Development expenses have been 5.22% of Revenue.
  • The Interest Expense is 1,047.71% of Operating Income.
  • The Net Earning history of VTRS is 0.35% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 27 years.

Viatris Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: VTRS
CUSIP: 92556V
Website: viatris.com

Debt

Debt-to-Equity Ratio: 0.88
Current Ratio: 1.53
Quick Ratio: 0.65

Price-to-Earnings

Trailing P/E Ratio: 229.1
Forward P/E Ratio: 4.28

VTRS Technical Analysis vs Fundamental Analysis

Sell
32
Viatris (VTRS) is a Sell

Is Viatris a Buy or a Sell?

  • Viatris stock is rated a Sell
    The current Viatris [VTRS] share price is $11.4550. The Score for VTRS is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.